id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-0621-0003,FDA,FDA-2022-N-0621,Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee; Renewal,Notice,Renewals,2026-04-27T04:00:00Z,2026,4,,,2026-04-27T17:18:57Z,2026-08125,0,0,09000064b92ad1da
FDA-2022-N-0621-0002,FDA,FDA-2022-N-0621,Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee; Renewal,Notice,Renewals,2024-08-05T04:00:00Z,2024,8,2024-08-05T04:00:00Z,,2024-08-05T17:17:12Z,2024-17248,0,0,0900006486619b98
FDA-2022-N-0621-0001,FDA,FDA-2022-N-0621,Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee; Renewal,Notice,Renewals,2022-05-05T04:00:00Z,2022,5,2022-05-05T04:00:00Z,,2022-05-05T19:04:50Z,2022-09610,0,0,0900006485051dca